Diffuse Large B-Cell Lymphoma (DLBCL) Clinical Trials in Hangzhou, Zhejiang
5 recruitingHangzhou, Zhejiang, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Guangzhou Lupeng Pharmaceutical Company LTD.150 enrolled41 locationsNCT07189065
Recruiting
Phase 2
Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Second Affiliated Hospital, School of Medicine, Zhejiang University48 enrolled1 locationNCT07078500
Recruiting
Phase 1Phase 2
A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.97 enrolled21 locationsNCT07124936
Recruiting
Not Applicable
Study of Pomalidomide Combination with Rituximab and Anti-PD-1 Antibody （PPR） in Third or Later Line Therapy of DLBCL
Diffuse Large B-Cell Lymphoma (DLBCL)
Zhejiang Cancer Hospital30 enrolled1 locationNCT06832228
Recruiting
Phase 1
Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)Mantle Cell Lymphoma (MCL)Primary Mediastinal B-cell Lymphoma (PMBCL)
Second Affiliated Hospital, School of Medicine, Zhejiang University52 enrolled1 locationNCT06464861